Updates are available Correction dated 2024-08-20
Click to view Correction: https://doi.org/10.1038/s41467-024-51394-7
-
Authors
Rajamani, Nanditha https://orcid.org/0000-0002-2511-9839
Friedrich, Helen
Butenko, Konstantin https://orcid.org/0000-0002-4509-4624
Dembek, Till
Lange, Florian
Navrátil, Pavel
Zvarova, Patricia
Hollunder, Barbara https://orcid.org/0000-0003-0104-6927
de Bie, Rob M. A.
Odekerken, Vincent J. J.
Volkmann, Jens
Xu, Xin
Ling, Zhipei
Yao, Chen
Ritter, Petra https://orcid.org/0000-0002-4643-4782
Neumann, Wolf-Julian
Skandalakis, Georgios P.
Komaitis, Spyridon
Kalyvas, Aristotelis
Koutsarnakis, Christos
Stranjalis, George
Barbe, Michael
Milanese, Vanessa
Fox, Michael D. https://orcid.org/0000-0001-8848-6399
Kühn, Andrea A. https://orcid.org/0000-0002-4134-9060
Middlebrooks, Erik
Li, Ningfei https://orcid.org/0000-0003-3315-3591
Reich, Martin https://orcid.org/0000-0001-9115-5136
Neudorfer, Clemens
Horn, Andreas https://orcid.org/0000-0002-0695-6025
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (424778381 – TRR 295)
- License Information
-
More Information
Article History
Received: 14 March 2023
Accepted: 13 May 2024
First Online: 31 May 2024
Change Date: 20 August 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41467-024-51394-7
Competing interests
: N.R., B.H. and A.H. serve as inventors on patent application by Charité – University Medicine Berlin that covers multitract fiberfiltering and the cleartune algorithm introduced in this work. The application has been submitted on July 21, 2023, with the patent office of Luxembourg (application #LU103178). A.H. reports lecture fees from Boston Scientific and is a consultant for FxNeuromodulation and Abbott unrelated to present work. W.J.N. received honoraria unrelated to present work from Medtronic that is a manufacturer of deep brain stimulation devices. E.M. declares the following funding sources and employment: Boston Scientific Corp: Advisory Board Member, Research Support, Varian Medical Systems: Clinical Trial Funding, Advisory Board Member, Speaker’s Bureau; Vigil Neuroscience, Inc: Clinical Trial Funding. A.A.K. reports personal fees from Medtronic and Boston Scientific. The remaining authors declare no competing interest.
